Bio Digital Patent
GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...
June 02, 2023 | News
The hospital's mobile applications are used by its staff and patients to access and manage medical records, schedule appointments, and communicate with hea...
May 10, 2023 | News
BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...
April 18, 2023 | News
The Honorable Valerie Caproni adopted the Report & Recommendation (R&R) of the Honorable Robert W. Lehrburger in full, including damages totaling o...
March 23, 2023 | News
Orion Health, a global leader in population health software, today announced that it has gained leading security credentials for two of its flagship produc...
February 08, 2023 | News
Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical te...
February 06, 2023 | News
The long-term relationships and immensity of the California market also made it a strategic advancement for the acquirer. Facilities and patients...
January 04, 2023 | News
-Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxi...
January 03, 2023 | News
ExoCoBio Inc., one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims tha...
May 09, 2022 | News
The United States Patent and Trademark Office (USPTO) has issued Patent US 11,181,529 B2: "Radical Dosimetry for the Analysis of Biopharmaceuticals and Bio...
December 10, 2021 | News
Secondly, OT networks are particularly vulnerable because they operate with many proprietary, and often legacy, devices that can be difficult to identify a...
August 18, 2021 | Opinion | By Guilad Regev, SVP Customer Care, Claroty
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two compa...
July 09, 2021 | News
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...
July 02, 2021 | News
Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its licenses of&...
June 25, 2021 | News
Most Read
Bio Jobs
News